ClinicalTrials.Veeva

Menu

Aspects of Vulnerability of People Living with HIV in the Alpine Arc Region (ASPEGIC)

C

Centre Hospitalier Annecy Genevois

Status

Completed

Conditions

HIV Infections

Treatments

Other: self questionnaire

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

HIV infection in France has become a chronic disease and treatment has allowed patients to increase their life expectancy. However, these promising results suffer from a very large variability within the socio-epidemiological subgroups, and life expectancy at 20 years of age is still one third lower than in the general population. Few studies of metropolitan cohorts investigated precariousness as an independent risk factor for mortality. The investigators chose to consider the vulnerability of people living with HIV (PLWHA) through the measurement of a validated French quantitative score, called EPICES ("Évaluation de la précarité et des inégalités de santé dans les centres d'examens de santé ", Evaluation of precariousness and health inequalities in health examination centers).

Full description

HIV infection in France has become a chronic disease and treatment has allowed patients to increase their life expectancy. However, these promising results suffer from a very large variability within the socio-epidemiological subgroups, and life expectancy at 20 years of age is still one third lower than in the general population. Few studies of metropolitan cohorts investigated precariousness as an independent risk factor for mortality. The investigators chose to consider the vulnerability of people living with HIV (PLWHA) through the measurement of a validated French quantitative score, called EPICES (Evaluation of precariousness and health inequalities in health examination centers). Using a self-administered questionnaire administered during an annual follow-up visit to an infectious disease specialist, the investigators seek to define in the alpine arc region in france, socio-demographic data associated with greater precariousness among PLWHA.

Enrollment

595 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any person living with HIV presenting for consultation with their infectious disease referrer.
  • Patient followed for at least 6 months for their HIV infection
  • Patient with undetectable or detectable HIV viral load
  • Patient of legal age at the time of the study
  • Patient informed of the study and having expressed no objection to the collection of health data

Exclusion criteria

  • Patient opposed or unable to express opposition to participation in the study
  • Patient is a minor at the time of the study
  • Patient taking antiretroviral therapy for less than 6 months

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

595 participants in 1 patient group

Self questionnaire
Other group
Description:
The study will be offered to all patients who have been treated for HIV infection for at least 6 months, during a follow-up consultation. A self questionnaire will be administered only once per patient during the usual consultation, there is no follow-up planned.
Treatment:
Other: self questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Lejeune Stéphanie; Janssen Cécile, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems